Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
108,488,554
-
Share change
-
+4,608,486
-
Total reported value
-
$1,160,926,758
-
Put/Call ratio
-
58%
-
Price per share
-
$10.69
-
Number of holders
-
189
-
Value change
-
+$41,634,303
-
Number of buys
-
92
-
Number of sells
-
56
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2021
As of 30 Sep 2021 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 108,488,554 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., UBS OCONNOR LLC, STATE STREET CORP, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, and PFM Health Sciences, LP.
This table shows 189 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.